BioSpace News Archive

Rallybio Corporation (“Rallybio”) (Nasdaq: RLYB) today announced the commencement of a proposed public offering of $75 million of its shares of common stock (and, in lieu of common stock to certain investors, pre-funded warrants to purchase shares of its common stock).

Xencor Presents Early Clinical Data from Combination Study of Vudalimab and New Data from Multiple Preclinical-stage XmAb ® Programs at the SITC Annual Meeting.

ScreenPro Security Inc. (CSE: SCRN) (OTCQB: SCRSF) (“ScreenPro” or the “Company”) is pleased to announce a non-brokered private placement financing of up to 20 million units of the Company (“Units”) at a price of $0.05 per Unit (the “Private Placement”).

Enavate Sciences , a portfolio company of Patient Square Capital, is pleased to announce that H. Edward (Edd) Fleming, Jr , M.D. has joined the firm as Executive Vice President, Commercialization.

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced a booster dose of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine (COMIRNATY ® Original/Omicron BA.4/BA.5 5/5-µg) has been recommended for marketing authorization by the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) for children 5 through 11 years of age.

Recently, Melax Tech, a world leader in biomedical Natural Language Processing (NLP) Technology, was nominated and selected to be part of Startup Creasphere’s Batch 9 Program, one of the largest innovation platforms for digital health solutions globally.

The global Parkinson’s disease treatment market size was estimated at around USD 4.3 billion in 2021 and it is projected to hit around USD 12.1 billion by 2030, growing at a CAGR of 12.18% from 2022 to 2030.

According to Vision Research Reports, the global vagus nerve stimulation market was valued at USD 673.02 million in 2021 and it is predicted to surpass around USD 1.59 billion by 2030 with a CAGR of 10.03% from 2022 to 2030.

According to latest report, the global respiratory antiviral treatment market size was reached at US$ 3 Bn in 2020 and is predicted to hit US$ 5.4 billion by 2030.

The nearly 200-year-old phrase “you are what you eat” has some new evidence. ISB researchers have found that the gut microbiome, including what we feed it, is largely responsible for the variation in circulating blood metabolites across people.